Halbert Hargrove Global Advisors’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q2
Sell
-4
Closed -$1.59K 417
2025
Q1
$1.59K Buy
+4
New +$1.61K ﹤0.01% 419
2023
Q2
Sell
-822
Closed -$378K 120
2023
Q1
$378K Buy
822
+26
+3% +$12.4K 0.03% 92
2022
Q4
$408K Sell
796
-83
-9% -$42.1K 0.03% 87
2022
Q3
$399K Sell
879
-1
-0.1% -$478 0.03% 85
2022
Q2
$425K Buy
880
+6
+0.7% +$2.97K 0.03% 80
2022
Q1
$430K Buy
874
+38
+5% +$17.4K 0.03% 87
2021
Q4
$387K Buy
836
+126
+18% +$53K 0.02% 96
2021
Q3
$265K Sell
710
-15
-2% -$5.7K 0.02% 115
2021
Q2
$277K Buy
725
+8
+1% +$3.06K 0.02% 118
2021
Q1
$257K Buy
717
+20
+3% +$6.43K 0.02% 106
2020
Q4
$224K Buy
+697
New +$214K 0.02% 105
2019
Q3
Sell
-708
Closed -$200K 89
2019
Q2
$200K Sell
708
-5
-0.7% -$1.37K 0.05% 79
2019
Q1
$205K Buy
+713
New +$206K 0.79% 42
2018
Q4
Sell
-735
Closed -$201K 84
2018
Q3
$201K Buy
+735
New +$191K 0.05% 73
2016
Q1
Sell
-1,838
Closed -$256K 83
2015
Q4
$256K Sell
1,838
-47
-2% -$6.47K 0.11% 77
2015
Q3
$264K Sell
1,885
-2,063
-52% -$310K 0.13% 68
2015
Q2
$648K Sell
3,948
-650
-14% -$104K 0.16% 53
2015
Q1
$710K Buy
4,598
+1,882
+69% +$268K 0.23% 50
2014
Q4
$341K Sell
2,716
-1,570
-37% -$194K 0.17% 71
2014
Q3
$513K Buy
4,286
+21
+0.5% +$2.41K 0.14% 54
2014
Q2
$459K Buy
4,265
+1,127
+36% +$116K 0.14% 49
2014
Q1
$312K Sell
3,138
-62
-2% -$5.61K 0.1% 79
2013
Q4
$296K Buy
+3,200
New +$284K 0.09% 93

Other funds holding ELV